News Industry News Resverlogix Expands Phase 2b Program with the Commencement of Dosing in SUSTAIN September 27, 2011
News Daily News Year in Review: Highlights of 2010 Include Data on Valvular Therapy, CTA Progress Caitlin E. Cox January 02, 2011